Heterodimeric proteins with fc mutations

TW202629614APending Publication Date: 2026-07-16ADAGENE AG
0 Cites 0 Cited by

Patent Information

Application Number
TW115107855
Authority / Receiving Office
TW · TW
Patent Type
Applications
Current Assignee / Owner
Filing Date
2021-01-22
Publication Date
2026-07-16
Patent Text Reader

Abstract

The present application provides heterodimeric proteins comprising polypeptides having CH3 domains with engineered residues that form disulfide bonds and / or salt bridges. Also provided are activatable antibodies targeting CD3 and / or HER2. Compositions, methods of manufacture and methods of treatment using the heterodimeric proteins and the activatable antibodies are further provided.
Need to check novelty before this filing date? Find Prior Art